ATE239739T1 - Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten - Google Patents

Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten

Info

Publication number
ATE239739T1
ATE239739T1 AT99956297T AT99956297T ATE239739T1 AT E239739 T1 ATE239739 T1 AT E239739T1 AT 99956297 T AT99956297 T AT 99956297T AT 99956297 T AT99956297 T AT 99956297T AT E239739 T1 ATE239739 T1 AT E239739T1
Authority
AT
Austria
Prior art keywords
inflammatory drugs
phospholipide
derivatives
steroid anti
compounds
Prior art date
Application number
AT99956297T
Other languages
English (en)
Inventor
Alexander Kozak
Israel Shapiro
Original Assignee
Dpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dpharm Ltd filed Critical Dpharm Ltd
Application granted granted Critical
Publication of ATE239739T1 publication Critical patent/ATE239739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99956297T 1998-11-19 1999-11-18 Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten ATE239739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12714398A IL127143A0 (en) 1998-11-19 1998-11-19 Phospholipid terivatives of non-steroidal anti inflammatory drugs
PCT/IL1999/000623 WO2000031083A1 (en) 1998-11-19 1999-11-18 Phospholipid derivatives of non-steroidal anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
ATE239739T1 true ATE239739T1 (de) 2003-05-15

Family

ID=11072158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99956297T ATE239739T1 (de) 1998-11-19 1999-11-18 Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten

Country Status (11)

Country Link
US (3) US6730696B1 (de)
EP (1) EP1131326B1 (de)
JP (1) JP2002530410A (de)
AT (1) ATE239739T1 (de)
AU (1) AU766045B2 (de)
CA (1) CA2346869C (de)
DE (1) DE69907720T2 (de)
IL (1) IL127143A0 (de)
NZ (1) NZ510938A (de)
WO (1) WO2000031083A1 (de)
ZA (1) ZA200102718B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127143A0 (en) 1998-11-19 1999-09-22 Dpharm Ltd Phospholipid terivatives of non-steroidal anti inflammatory drugs
US7410956B2 (en) * 2002-02-11 2008-08-12 Vertex Pharmaceuticals Incorporated Caspase inhibitor prodrugs
US20070053984A1 (en) * 2005-03-03 2007-03-08 Monique Spann-Wade Topical gels compositions
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
CA2703838A1 (en) * 2007-10-30 2009-05-07 Athera Biotechnologies Ab Diagnostic and therapeutic methods and compositions for cardiovascular disease
US20130244982A1 (en) * 2010-12-02 2013-09-19 Bengurion University Of The Negev Research And Development Authority Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
WO2021262892A1 (en) * 2020-06-23 2021-12-30 The Trustees Of The University Of Pennsylvania Compositions and methods of using a pla2-responsive drug delivery system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US5352673A (en) * 1989-08-29 1994-10-04 Dennis Edward A Prodrugs
WO1991016920A1 (en) * 1990-05-07 1991-11-14 Vical, Inc. Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
US5563257A (en) * 1990-08-20 1996-10-08 Boehringer Mannheim Gmbh Phospholipid derivatives of nucleosides
US5256641A (en) 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
US5149794A (en) 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
US5543389A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
AU668873B2 (en) 1991-07-12 1996-05-23 Chimerix, Inc. Antiviral liponucleosides: treatment of hepatitis B
JPH07188280A (ja) * 1993-12-28 1995-07-25 L T T Kenkyusho:Kk ホスファチジルエタノールアミン類結合生理活性物質およびその中間体
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
WO1996022780A1 (en) 1995-01-27 1996-08-01 The Board Of Regents Of The University Of Texas System Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein
JP3781877B2 (ja) * 1997-10-03 2006-05-31 株式会社ムック アスコルビン酸誘導体またはその塩、および医薬
IL127143A0 (en) * 1998-11-19 1999-09-22 Dpharm Ltd Phospholipid terivatives of non-steroidal anti inflammatory drugs

Also Published As

Publication number Publication date
EP1131326A1 (de) 2001-09-12
EP1131326A4 (de) 2002-03-27
DE69907720T2 (de) 2004-02-26
US20040147485A1 (en) 2004-07-29
AU766045B2 (en) 2003-10-09
IL127143A0 (en) 1999-09-22
US6730696B1 (en) 2004-05-04
US7417035B2 (en) 2008-08-26
NZ510938A (en) 2002-11-26
WO2000031083A1 (en) 2000-06-02
AU1292800A (en) 2000-06-13
DE69907720D1 (de) 2003-06-12
EP1131326B1 (de) 2003-05-07
US20070191310A1 (en) 2007-08-16
ZA200102718B (en) 2001-10-05
US7173018B2 (en) 2007-02-06
CA2346869C (en) 2010-03-23
CA2346869A1 (en) 2000-06-02
JP2002530410A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
ATE208397T1 (de) Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe
NO982294L (no) Farmas°ytiske blandinger omfattende flurbiprofen
ATE493983T1 (de) Thalidomide und dexamethason für die behandlung von tumors
DK1104758T3 (da) Acetylenderivativer som anti-inflammatoriske/analgesiske lægemidler
EP0738152A4 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure-derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
ATE306261T1 (de) Antithrombosemittel
DE69830504D1 (de) Antithrombotische mitteln
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
BR9803300A (pt) Formulação farmacêutica.
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
SE9801494D0 (sv) Novel use
DE69907720D1 (de) Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
IT1291550B1 (it) Derivati della colchicina e della tiocolchicina ad attivita' antinfiammatoria e miorilassante
AR029320A1 (es) Acidos aril carboxilicos y derivados de tetrazol, un proceso para su fabricacion, una composicion farmaceutica y el uso de los mismos para la produccion de un medicamento
DE69819539D1 (de) Antithrombotische mittel
IT1318667B1 (it) Medicamento antinfiammatorio.
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DE69828522D1 (de) Antithrombotische mittel
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties